These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37638690)

  • 1. Pyronaridine: a review of its clinical pharmacology in the treatment of malaria.
    Chu WY; Dorlo TPC
    J Antimicrob Chemother; 2023 Oct; 78(10):2406-2418. PubMed ID: 37638690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
    Pryce J; Hine P
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD006404. PubMed ID: 30620055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of pyronaridine anti-malarial properties and product characteristics.
    Croft SL; Duparc S; Arbe-Barnes SJ; Craft JC; Shin CS; Fleckenstein L; Borghini-Fuhrer I; Rim HJ
    Malar J; 2012 Aug; 11():270. PubMed ID: 22877082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial.
    Poravuth Y; Socheat D; Rueangweerayut R; Uthaisin C; Pyae Phyo A; Valecha N; Rao BH; Tjitra E; Purnama A; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L
    PLoS One; 2011 Jan; 6(1):e14501. PubMed ID: 21267072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays.
    Kurth F; Pongratz P; Bélard S; Mordmüller B; Kremsner PG; Ramharter M
    Malar J; 2009 Apr; 8():79. PubMed ID: 19389221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
    Roth JM; Sawa P; Makio N; Omweri G; Osoti V; Okach S; Choy F; Schallig HDFH; Mens P
    Malar J; 2018 May; 17(1):199. PubMed ID: 29764419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.
    Bukirwa H; Unnikrishnan B; Kramer CV; Sinclair D; Nair S; Tharyan P
    Cochrane Database Syst Rev; 2014 Mar; (3):CD006404. PubMed ID: 24596021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa.
    Ringwald P; Bickii J; Basco L
    Lancet; 1996 Jan; 347(8993):24-8. PubMed ID: 8531545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyronaridine-artesunate combination therapy for the treatment of malaria.
    Kurth F; Bélard S; Basra A; Ramharter M
    Curr Opin Infect Dis; 2011 Dec; 24(6):564-9. PubMed ID: 21986615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Pyronaridine-Artesunate for the Treatment of Uncomplicated
    Han KT; Lin K; Han ZY; Myint MK; Aye KH; Thi A; Thapa B; Bustos MD; Borghini-Fuhrer I; Ringwald P; Duparc S
    Am J Trop Med Hyg; 2020 Sep; 103(3):1088-1093. PubMed ID: 32524960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon.
    Ramharter M; Kurth F; Schreier AC; Nemeth J; Glasenapp Iv; Bélard S; Schlie M; Kammer J; Koumba PK; Cisse B; Mordmüller B; Lell B; Issifou S; Oeuvray C; Fleckenstein L; Kremsner PG
    J Infect Dis; 2008 Sep; 198(6):911-9. PubMed ID: 18694333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyronaridine-artesunate versus mefloquine plus artesunate for malaria.
    Rueangweerayut R; Phyo AP; Uthaisin C; Poravuth Y; Binh TQ; Tinto H; Pénali LK; Valecha N; Tien NT; Abdulla S; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
    N Engl J Med; 2012 Apr; 366(14):1298-309. PubMed ID: 22475593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyronaridine-artesunate or dihydroartemisinin-piperaquine combined with single low-dose primaquine to prevent
    Stone W; Mahamar A; Sanogo K; Sinaba Y; Niambele SM; Sacko A; Keita S; Youssouf A; Diallo M; Soumare HM; Kaur H; Lanke K; Ter Heine R; Bradley J; Issiaka D; Diawara H; Traore SF; Bousema T; Drakeley C; Dicko A
    Lancet Microbe; 2022 Jan; 3(1):e41-e51. PubMed ID: 35028628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short report: effects of pyronaridine on gametocytes in patients with acute uncomplicated falciparum malaria.
    Ringwald P; Meche FS; Basco LK
    Am J Trop Med Hyg; 1999 Sep; 61(3):446-8. PubMed ID: 10497988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UK malaria treatment guidelines 2016.
    Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
    J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Pyronaridine-Artesunate plus Single-Dose Primaquine for Treatment of Uncomplicated
    Leang R; Mairet-Khedim M; Chea H; Huy R; Khim N; Mey Bouth D; Dorina Bustos M; Ringwald P; Witkowski B
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
    Pryce J; Taylor M; Fox T; Hine P
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD006404. PubMed ID: 35726133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study.
    Tona Lutete G; Mombo-Ngoma G; Assi SB; Bigoga JD; Koukouikila-Koussounda F; Ntamabyaliro NY; Ntoumi F; Agnandji ST; Groger M; Shin J; Borghini-Fuhrer I; Arbe-Barnes S; Allen SJ; Kremsner PG; Miller R; Duparc S; Ramharter M;
    PLoS Med; 2021 Jun; 18(6):e1003669. PubMed ID: 34129601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.